CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 3 of 3 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT03556800 Org: User:

Start: 05/22/18 End: 06/30/22 Due: 06/30/23

Phase: N/A Priority: Normal

NCT ID: NCT03352076 Org: User:

Start: 12/28/17 End: 05/26/20 Due: 05/26/21

Phase: N/A Priority: Normal

NCT ID: NCT03770065 Org: User:

Start: 11/19/18 End: 04/08/20 Due: 04/08/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.	NCT03556800	Viramal Limited	user2@example.com	None	2018-05-22	2022-06-30	2023-06-30	-	-	2025-07-14
Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy	NCT03352076	Viramal Limited	user2@example.com	None	2017-12-28	2020-05-26	2021-05-26	-	-	2025-07-14
Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women	NCT03770065	Viramal Limited	user2@example.com	None	2018-11-19	2020-04-08	2021-04-08	-	-	2025-07-14